Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in re… Read more
Pulsenmore Ltd. Ordinary Shares (PLSM) - Net Assets
Latest net assets as of June 2025: $24.44 Million USD
Based on the latest financial reports, Pulsenmore Ltd. Ordinary Shares (PLSM) has net assets worth $24.44 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($35.58 Million) and total liabilities ($11.14 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $24.44 Million |
| % of Total Assets | 68.68% |
| Annual Growth Rate | 92.03% |
| 5-Year Change | 1627.71% |
| 10-Year Change | N/A |
| Growth Volatility | 1209.52 |
Pulsenmore Ltd. Ordinary Shares - Net Assets Trend (2019–2024)
This chart illustrates how Pulsenmore Ltd. Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Pulsenmore Ltd. Ordinary Shares (2019–2024)
The table below shows the annual net assets of Pulsenmore Ltd. Ordinary Shares from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $28.37 Million | -25.71% |
| 2023-12-31 | $38.20 Million | -30.60% |
| 2022-12-31 | $55.03 Million | +7.28% |
| 2021-12-31 | $51.30 Million | +3023.49% |
| 2020-12-31 | $1.64 Million | +51.34% |
| 2019-12-31 | $1.09 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pulsenmore Ltd. Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4287108000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $548.90 | 0.00% |
| Other Comprehensive Income | $3.01 Million | 11.32% |
| Other Components | $69.49 Million | 261.34% |
| Total Equity | $26.59 Million | 100.00% |
Pulsenmore Ltd. Ordinary Shares Competitors by Market Cap
The table below lists competitors of Pulsenmore Ltd. Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Olidata S.p.A.
F:OL40
|
$8.66 Million |
|
InterServ International Inc.
TWO:6169
|
$8.66 Million |
|
Rifa Ind
KO:000760
|
$8.66 Million |
|
Micro Leasing Public Company Limited
BK:MICRO
|
$8.67 Million |
|
INNOVATEC S.P.A.
F:5JT
|
$8.66 Million |
|
Fun Yours Technology Co Ltd
TWO:6482
|
$8.65 Million |
|
NexgenRx Inc
PINK:NEGXF
|
$8.65 Million |
|
Max Power Mining Corp.
PINK:MAXXF
|
$8.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pulsenmore Ltd. Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 36,418,015 to 26,590,637, a change of -9,827,378 (-27.0%).
- Net loss of 10,082,195 reduced equity.
- New share issuances of 3,000 increased equity.
- Other comprehensive income increased equity by 170,966.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.08 Million | -37.92% |
| Share Issuances | $3.00K | +0.01% |
| Other Comprehensive Income | $170.97K | +0.64% |
| Other Changes | $80.85K | +0.3% |
| Total Change | $- | -26.98% |
Book Value vs Market Value Analysis
This analysis compares Pulsenmore Ltd. Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 23.86x to 1.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.18 | $4.20 | x |
| 2020-12-31 | $0.15 | $4.20 | x |
| 2021-12-31 | $9.65 | $4.20 | x |
| 2022-12-31 | $8.83 | $4.20 | x |
| 2023-12-31 | $5.69 | $4.20 | x |
| 2024-12-31 | $4.15 | $4.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pulsenmore Ltd. Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -37.92%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -380.25%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 1.46x
- Recent ROE (-37.92%) is above the historical average (-117.16%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -117.29% | 0.00% | 0.00x | 1.60x | $-1.38 Million |
| 2020 | -475.00% | 0.00% | 0.00x | 3.12x | $-4.37 Million |
| 2021 | -16.67% | -1623.89% | 0.01x | 1.09x | $-13.19 Million |
| 2022 | -11.80% | -204.54% | 0.05x | 1.26x | $-11.61 Million |
| 2023 | -44.29% | -946.46% | 0.03x | 1.36x | $-19.77 Million |
| 2024 | -37.92% | -380.25% | 0.07x | 1.46x | $-12.74 Million |
Industry Comparison
This section compares Pulsenmore Ltd. Ordinary Shares's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $24.44 Million | -117.29% | 0.46x | $8.66 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |